How many shares of REGN does CHARLES SCHWAB INVESTMENT MANAGEMENT INC own?

As of 2026-Q2, CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 846,306 shares of REGN (REGENERON PHARMACEUTICALS).

What is CHARLES SCHWAB INVESTMENT MANAGEMENT INC's REGN position worth?

As of 2026-Q2, CHARLES SCHWAB INVESTMENT MANAGEMENT INC's REGN position is worth $527.7M.

Is CHARLES SCHWAB INVESTMENT MANAGEMENT INC buying or selling REGN?

In 2026-Q2, CHARLES SCHWAB INVESTMENT MANAGEMENT INC increased their REGN position (+5.2% change in shares).

When did CHARLES SCHWAB INVESTMENT MANAGEMENT INC first buy REGN?

Based on available 13F filings, CHARLES SCHWAB INVESTMENT MANAGEMENT INC first reported a position in REGN in 2018-Q4. They have held the position across 31 quarters.

Back to

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

REGN
31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in REGENERON PHARMACEUTICALS

Current Value

$527.7M

Current Shares

846,306

Total Value Change

+$416.9M

Total Shares Change

+549,566

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	846,306	+5.2%	$527.7M	0.1%	$622.81	33
2026-Q1	Increased	804,508	+3.4%	$621.6M	0.1%	$770.59	33
2025-Q4	Increased	778,001	+3.0%	$600.5M	0.1%	$768.90	32
2025-Q3	Increased	755,565	+4.9%	$424.8M	0.1%	$559.40	33
2025-Q2	Increased	720,273	+2.0%	$378.1M	0.1%	$521.53	32
2025-Q1	Increased	706,440	+1.5%	$448M	0.1%	$629.11	32
2024-Q4	Increased	695,799	+3.4%	$495.6M	0.1%	$705.67	32
2024-Q3	Increased	673,261	+1.7%	$707.8M	0.1%	$1,041.41	38
2024-Q2	Increased	661,762	+3.7%	$695.5M	0.1%	$1,041.20	39
2024-Q1	Increased	638,223	+2.8%	$614.3M	0.1%	$953.49	39
2023-Q4	Increased	620,616	+3.8%	$545.1M	0.1%	$870.08	39
2023-Q3	Decreased	598,058	-0.3%	$492.2M	0.1%	$815.27	0
2023-Q2	Increased	600,036	+0.7%	$431.2M	0.1%	$711.82	37
2023-Q1	Increased	595,604	+1.5%	$489.4M	0.1%	$813.99	38
2022-Q4	Increased	586,943	+2.4%	$423.5M	0.1%	$714.75	38
2022-Q3	Increased	573,003	+0.5%	$394.7M	0.1%	$682.43	37
2022-Q2	Increased	570,462	+1.5%	$337.2M	0.1%	$585.60	38
2022-Q1	Increased	562,136	+1.1%	$392.6M	0.1%	$691.89	38
2021-Q4	Increased	556,294	+5.0%	$351.3M	0.1%	$625.62	39
2021-Q3	Increased	529,528	+4.9%	$320.5M	0.1%	$599.52	39
2021-Q2	Increased	504,883	+1.0%	$282M	0.1%	$553.32	31
2021-Q1	Decreased	499,790	-3.2%	$236.5M	0.1%	$468.72	0
2020-Q4	Increased	516,149	+1.2%	$249.4M	0.1%	$478.59	31
2020-Q3	Increased	510,164	+8.2%	$285.6M	0.1%	$554.55	40
2020-Q2	Increased	471,523	+32.0%	$294.1M	0.1%	$617.82	47
2020-Q1	Increased	357,097	+0.1%	$174.4M	0.1%	$483.73	36
2019-Q4	Decreased	356,916	-3.5%	$134M	0.1%	$371.97	0
2019-Q3	Decreased	369,700	-6.1%	$102.6M	0.1%	$274.81	0
2019-Q2	Increased	393,868	+6.6%	$123.3M	0.1%	$310.07	32
2019-Q1	Increased	369,328	+24.5%	$151.7M	0.1%	$406.78	37
2018-Q4	New	296,740	-	$110.8M	0.1%	$370.01	42

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

REGN31 quarters

REGN
31 quarters